BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2009
View Archived Issues
Novel tools for post-transplant tacrolimus dose optimization reported
Read More
Banyu describes 4-sulfonylpiperidine derivatives for the treatment of diabetes
Read More
Kitasato Institute and Kyowa Hakko Kirin claim novel KB-3346-5 substances as antiinfective agents
Read More
Improved early virologic response rates seen with GI-5005 in phase II HCV study
Read More
Preclinical data on phase I antiangiogenic mAb, PF-03446962, presented
Read More
AEZS-126, a new orally bioavailable PI3K inhibitor shows preclinical antitumor activity
Read More
Intravitreal viral delivery of VEGF antagonist developed as therapy for ocular neovascularization
Read More
Intarcia completes enrollment in phase Ib clinical study of ITCA-650 in type 2 diabetes
Read More
Novel multitargeted kinase inhibitor displays potent antitumor activity in preclinical cancer models
Read More
Choongwae patents GSK-3beta inhibitors for the treatment of Alzheimer's disease
Read More
Novel PI3K inhibitors for cancer treatment jointly patented by Genentech and Roche
Read More
Antisense begins pivotal phase III trabedersen trial in aggressive brain tumors
Read More
Avila Therapeutics' novel agent AVL-181 silences HCV protease activity
Read More
Peregrine presents preliminary phase II bavituximab data in breast cancer
Read More
Pharmasset and Roche dose first patient in phase IIb clinical trial of HCV drug R-7128
Read More
CHMP recommends approval of pediatric formulation of Tracleer in PAH
Read More
Clinical study shows anti-HCV efficacy of NIM-811 with peginterferon
Read More
Janssen receives Japanese approval to market Risperdal Consta for schizophrenia
Read More
European Commission grants Wyeth marketing authorization for Conbriza
Read More
Novel Aurora kinase inhibitors claimed by Bayer for cancer treatment
Read More
FDA accepts for review Theravance's complete response for telavancin in cSSSI
Read More
FDA grants orphan drug designation to Pharming's Prodarsan for Cockayne syndrome
Read More
Phase III Nexavar trial in advanced melanoma does not meet primary endpoint
Read More
Phase II GSK-1838262 results reported for pain in diabetic peripheral neuropathy
Read More
Sepracor reports preliminary phase III Omnaris results in allergic rhinitis
Read More
Once-daily antiepileptic Zebinix approved in the European Union
Read More